Research Paper Volume 11, Issue 16 pp 6503—6521

Procollagen-lysine, 2-oxoglutarate 5-dioxygenases 1, 2, and 3 are potential prognostic indicators in patients with clear cell renal cell carcinoma


Figure 6. Genetic mutations in PLODs family members and their association with OS and DFS of ccRCC patients (cBioPortal). A total of 3.1% mutation rate of PLODs was observed in ccRCC patients. Genetic mutation alterations rate of PLOD1, PLOD2 and PLOD3 were 0.4%, 1.2% and 1.5%, respectively (A). Genetic alterations in PLODs were associated with shorter OS (B) and DFS (C) of ccRCC patients.